Pfizer posts Q1FY22 PAT of Rs. 199.91 Cr
The company posted net profit of Rs.124.45 crores for the period ended June 30, 2020.
The company posted net profit of Rs.124.45 crores for the period ended June 30, 2020.
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
Adjusted PAT declined 18.8% YoY
Revenue from operations for the year ended March 31, 2021 is ?2,239 crore
The company has posted net profit of Rs.397.06 crores for the 9 months period ended December 31, 2020.
India in the Changing Landscape of Life-Sciences Research & Development
Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
Call it a major milestone in bladder cancer therapy that aims to provide a lifeline for patients who previously had limited options
Subscribe To Our Newsletter & Stay Updated